Adolescent bulimia nervosa

Curr Psychiatry Rep. 2012 Aug;14(4):391-7. doi: 10.1007/s11920-012-0280-0.

Abstract

Onset of bulimia nervosa (BN) typically occurs in adolescence and is frequently accompanied by medical and psychiatric sequelae that may have detrimental effects on adolescent development. Potentially serious medical consequences and high comorbid rates of mood disorders and suicidality underscore the need for early recognition and effective treatments. Research among adolescents with BN has lagged behind that of adults, although evidence is accumulating to support the efficacy of family-based interventions and cognitive behavioral treatments that are adapted for use with adolescent populations. The aim of the current article is to provide an overview of recent research on epidemiology, risk factors, diagnostic issues, and treatment interventions focusing on adolescent BN, and to highlight areas for future research.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Antidepressive Agents, Second-Generation / therapeutic use
  • Bulimia Nervosa* / diagnosis
  • Bulimia Nervosa* / epidemiology
  • Bulimia Nervosa* / therapy
  • Diagnostic and Statistical Manual of Mental Disorders
  • Humans
  • Psychotherapy / methods
  • Risk Factors
  • United States / epidemiology

Substances

  • Antidepressive Agents, Second-Generation